<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2C430FDC-E426-457C-A230-0FC0F7D9155C"><gtr:id>2C430FDC-E426-457C-A230-0FC0F7D9155C</gtr:id><gtr:name>Draper Laboratory</gtr:name><gtr:address><gtr:line1>555 Technology Square</gtr:line1><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/60B71C12-9A8A-4C09-B2C3-88FC51ECE8FB"><gtr:id>60B71C12-9A8A-4C09-B2C3-88FC51ECE8FB</gtr:id><gtr:name>Brigham and Women's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/85FF6668-D8FB-4B1B-9A9C-7A4A10BDD216"><gtr:id>85FF6668-D8FB-4B1B-9A9C-7A4A10BDD216</gtr:id><gtr:name>Imagen Therapeutics</gtr:name><gtr:address><gtr:line1>Suit 4D,Citylabs</gtr:line1><gtr:line2>Nelson Street</gtr:line2><gtr:postCode>M13 9NQ</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/007E0817-B05C-490A-B38A-2EDA79558DDD"><gtr:id>007E0817-B05C-490A-B38A-2EDA79558DDD</gtr:id><gtr:name>Boston University</gtr:name><gtr:address><gtr:line1>One Sherborn Street</gtr:line1><gtr:line2>Boston</gtr:line2><gtr:line3>Massachusetts</gtr:line3><gtr:line4>MA 02215</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Research Support Services</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2C430FDC-E426-457C-A230-0FC0F7D9155C"><gtr:id>2C430FDC-E426-457C-A230-0FC0F7D9155C</gtr:id><gtr:name>Draper Laboratory</gtr:name><gtr:address><gtr:line1>555 Technology Square</gtr:line1><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/60B71C12-9A8A-4C09-B2C3-88FC51ECE8FB"><gtr:id>60B71C12-9A8A-4C09-B2C3-88FC51ECE8FB</gtr:id><gtr:name>Brigham and Women's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/58930F3F-9B16-4DC2-833F-C72033E77A1E"><gtr:id>58930F3F-9B16-4DC2-833F-C72033E77A1E</gtr:id><gtr:name>Boston Children's Hospital</gtr:name><gtr:address><gtr:line1>Boston Childrens Hospital</gtr:line1><gtr:line2>Karp Building</gtr:line2><gtr:line3>9th floor, Rm 09210 1 Blackfan Circle</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/85FF6668-D8FB-4B1B-9A9C-7A4A10BDD216"><gtr:id>85FF6668-D8FB-4B1B-9A9C-7A4A10BDD216</gtr:id><gtr:name>Imagen Therapeutics</gtr:name><gtr:address><gtr:line1>Suit 4D,Citylabs</gtr:line1><gtr:line2>Nelson Street</gtr:line2><gtr:postCode>M13 9NQ</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/007E0817-B05C-490A-B38A-2EDA79558DDD"><gtr:id>007E0817-B05C-490A-B38A-2EDA79558DDD</gtr:id><gtr:name>Boston University</gtr:name><gtr:address><gtr:line1>One Sherborn Street</gtr:line1><gtr:line2>Boston</gtr:line2><gtr:line3>Massachusetts</gtr:line3><gtr:line4>MA 02215</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E12BA2D5-637A-4E09-9ECE-5631E44DFABA"><gtr:id>E12BA2D5-637A-4E09-9ECE-5631E44DFABA</gtr:id><gtr:name>CIMIT</gtr:name><gtr:address><gtr:line1>165 Cambridge Street</gtr:line1><gtr:line2>Suite 702</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F6ED1986-82DE-4527-90DB-3497C0C8739C"><gtr:id>F6ED1986-82DE-4527-90DB-3497C0C8739C</gtr:id><gtr:firstName>Jackie</gtr:firstName><gtr:surname>Oldham</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0E562AB1-03D2-46F1-BAEA-FB2B3EC74190"><gtr:id>0E562AB1-03D2-46F1-BAEA-FB2B3EC74190</gtr:id><gtr:firstName>Gus</gtr:firstName><gtr:surname>McGrouther</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E849C247-E3C0-4AFA-AEDA-321EDE647FA8"><gtr:id>E849C247-E3C0-4AFA-AEDA-321EDE647FA8</gtr:id><gtr:firstName>Simon James</gtr:firstName><gtr:surname>Gaskell</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E96ECDF7-11A7-4661-8957-0C0BE70D5271"><gtr:id>E96ECDF7-11A7-4661-8957-0C0BE70D5271</gtr:id><gtr:firstName>Sandra</gtr:firstName><gtr:surname>Downes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/ABF28B5B-11CC-43A8-B508-0A7DC02B8BC4"><gtr:id>ABF28B5B-11CC-43A8-B508-0A7DC02B8BC4</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Baker</gtr:surname><gtr:orcidId>0000-0002-4592-6427</gtr:orcidId><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FG041733%2F1"><gtr:id>0A61F05E-9171-4571-BA21-FBE24B5D8F44</gtr:id><gtr:title>Innovative Technology for Healthcare Delivery - The MIMIT: CIMIT Collaboration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/G041733/1</gtr:grantReference><gtr:abstractText>Manchester Integrating Medicine and Innovative Technology (MIMIT) is the first international affiliate of the Center for Integration of Medicine and Innovative Technology, Boston (CIMIT). CIMIT is a 10year old initiative and is a highly successful example of nurturing innovations in medical and heath technology. MIMIT is led by the University of Manchester in collaboration with six partner NHS organisations. These include: Central Manchester and Manchester Children's NHS Trust; University Hospital of South Manchester Foundation Trust; Salford Royal Foundation Trust; Christie Hospital NHS Foundation Trust; Mental Health &amp;amp; Social Care Trust and Salford Primary Care Trust (www.mimit.org.uk). CIMIT comprises a consortium of world class hospitals and academic institutions based in Boston, Massachusetts. These include: Massachusetts General Hospital; Brigham and Women's Hospital; Newton-Wellesley Hospital; Beth Israel Deaconess Medical Centre; Children's Hospital Boston; Boston Medical Centre; the Charles Stark Draper Laboratory; Boston University; Massachusetts Institute of Technology; VA Boston Healthcare System and Harvard Medical School (www.cimit.org).The aim of the Manchester: Boston partnership is to accelerate the scope and development of new healthcare technologies and enable them to benefit patient care faster and more effectively. This aim is realised through a collaborative bridge that:-identifies unmet clinical need and gaps in knowledge to address that need.-optimises partnerships to address knowledge gaps and then invests in the partnership to develop the best technology solutions.-optimises mechanisms to accelerate and sustain project momentum thereby enhancing opportunities for transfer of technology and expertise.-enables close co-operation with end-users on both continents to facilitate rapid uptake into clinical care and translation for patient benefit.-optimises opportunity for collaboration with industry partners.</gtr:abstractText><gtr:fund><gtr:end>2012-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1293604</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration between Nicola Tirelli and Mark Grinstaff</gtr:description><gtr:id>E14767C2-4F03-40E5-ADB9-72FFD3E3716B</gtr:id><gtr:outcomeId>b971de78b971de8c-1</gtr:outcomeId><gtr:piContribution>The collaboration between Nicola Tirelli (University of Manchester) and Mark Grinstaff (Boston University, US) was a part building the joint MIMIT-CIMIT Science Bridge activity. The collaboration between Nicola and Mark has been to combine their complimentary expertise to develop multi-compartment carriers for combining and targeting medical treatments, such as those agents for psoriasis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imagen Therapeutics</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration between Guy Makin and Imagen Therapeutics</gtr:description><gtr:id>AB5736C9-82AA-44C9-AB0F-77C56E528D2D</gtr:id><gtr:impact>Two publications, as previously reported. Two grant applications, both unsuccessful.</gtr:impact><gtr:outcomeId>58c66f66bc9893.24637499-1</gtr:outcomeId><gtr:partnerContribution>Colleagues in Boston used the University of Manchester (UoM) cell lines to test hypotheses, and applied the UoM drug testing approach in their experimental set-up.</gtr:partnerContribution><gtr:piContribution>The University of Manchester hosted colleague from Boston, provided cell lines and expertise in pre-clinical drug testing. The collaborative mutually authored two papers from the research and collaborated on further grant applications.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration between Muhammad Zaman and Guy Makin</gtr:description><gtr:id>4505E4E9-64B6-429D-8829-CB2DD1CE29D9</gtr:id><gtr:impact>Discussions with Spinout company progressing to develop high throughput imaging based assays using primary human tumour material</gtr:impact><gtr:outcomeId>b971e328b971e346-1</gtr:outcomeId><gtr:partnerContribution>Similar contribution to above</gtr:partnerContribution><gtr:piContribution>Successful research collaboration where both individuals are actively seeking further funding to continue their collaboration. Three applications for further funding have been submitted. The collaboration between Guy Makin (University of Manchester) and Muhammad Zaman (Boston University, US) was a product of the joint MIMIT-CIMIT Science Bridge activity. A call for proposals to bring together PI's from Manchester and Boston resulted in an application for project funding from Guy and Muhammad and has led to both actively seeking further funding to continue their research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brigham and Women's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration between Karl Herholz and Ron Kikinis</gtr:description><gtr:id>383BEF32-3318-4898-B0E5-AC89CAD130E4</gtr:id><gtr:impact>The grant form a crucial component of the two major brain tumour projects funded under CRUK &amp;amp; EPSRC Cancer Imaging Centre in Cambridge and Manchester (http://www.cam-man-cic.ac.uk). Approximately &amp;pound;2.7 million total award for the Manchester site of which Prof Jackson is the PI and DJ Coope is co-investigator. The brain tumour studies both involve validation of novel imaging techniques as potential biomarkers against tissue samples, both the target definition and the vital recording of the locations of tissue samples builds upon knowledge and experience acquired through the MIMIT:CIMIT collaboration.</gtr:impact><gtr:outcomeId>b971e1fcb971e21a-1</gtr:outcomeId><gtr:partnerContribution>Software originally developed by Ron Kikinis was refined in a collaborative effort to enable PET guided biopies to be taken from glioma patients. The software refinements by the Manchester group have been implemented and resulted in enabling neurosurgeons to test the system with patients at Salford Royal Hospital.</gtr:partnerContribution><gtr:piContribution>The collaboration between Karl Herholz (University of Manchester) and Ron Kikinis (Harvard Medical School, Brigham and Women's Hospital) was a product of the joint MIMIT-CIMIT Science Bridge activity. A call for proposals to bring together PI's from Manchester and Boston resulted in an application for project funding from Karl and Ron and has led to further funding granted to build on the research undertaken.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brigham and Women's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration between Geoff Parker, Hugh McCann and Ron Kikinis</gtr:description><gtr:id>C9597C8A-193D-4449-8EF1-D135193D7F24</gtr:id><gtr:impact>The collaboration between Geoff Parker, Hugh McCann (both University of Manchester) and Ron Kikinis (Harvard medical School, Brigham and Women's Hospital, US) was part of the joint MIMIT-CIMIT Science Bridge activity. The collaboration has been to develop a methodology enabling the integration of images from magnetic resonance imaging (Geoff) and electrical impedance tomography (Hugh) using the 3D SLICER software (Ron). The aim is to achieve high temporal and spatial resolution to monitor key physiological functions such as that of the lung. The relationship is being further strengthen with the potential visit of a PDRA in Hugh McCann's group to Ron Kikinis's lab.</gtr:impact><gtr:outcomeId>b971e80ab971e828-1</gtr:outcomeId><gtr:partnerContribution>Support for Dr Natasa Terzija to spend an agreed amount of time over in Boston, USA with Prof Ron Kikinis as part of her application to the EPSRC for a 5-year early-career Research Fellowship.</gtr:partnerContribution><gtr:piContribution>The collaboration between Geoff Parker, Hugh McCann (both University of Manchester) and Ron Kikinis (Harvard medical School, Brigham and Women's Hospital, US) was part of the joint MIMIT-CIMIT Science Bridge activity. The collaboration has been to develop a methodology enabling the integration of images from magnetic resonance imaging (Geoff) and electrical impedance tomography (Hugh) using the 3D SLICER software (Ron). The aim is to achieve high temporal and spatial resolution to monitor key physiological functions such as that of the lung. The relationship is being further strengthen with the potential visit of a PDRA in Hugh McCann's group to Ron Kikinis's lab.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration between Jarrod Homer and Bob Hillman</gtr:description><gtr:id>532679ED-9649-4B33-B521-92288A0AC27F</gtr:id><gtr:outcomeId>b971dac2b971dad6-1</gtr:outcomeId><gtr:piContribution>The collaboration between Jarrod Homer (University of Manchester) and Bob Hillman (Massachusetts General Hospital, US) was a product of the joint MIMIT-CIMIT Science Bridge activity. A call for proposals to bring together PI's from Manchester and Boston resulted in an application for project funding from Jarrod and Bob to develop an objective analysis of voice quality. The collaboration between Jarrod and Bob has lead to the sharing of materials and voice samples with which to develop a novel voice quality algorithm that would assess voice disorders in a quantitative manner. Current practice is through a qualitative test which is subjective, giving rise to variations in test results. A quantitative method would provide a significant reduction in variation of test results and has the opportunity to identify voice disorders at a much earlier stage.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Draper Laboratory</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration between Steve Fowler and James Comolli</gtr:description><gtr:id>F74B8115-D210-4C93-A2A6-70F263F07A2D</gtr:id><gtr:outcomeId>b971e972b971e986-1</gtr:outcomeId><gtr:piContribution>The collaboration between Steve Fowler (University of Manchester) and James Comolli (Draper Lab, US) was a part of the joint MIMIT-CIMIT Science Bridge activity. The collaboration has been to identify biomarkers of infection from breath samples collected from mechanically ventilated patients. Steve's clinical expertise and interest in breath sample biomarkers has complemented James's expertise in mass spectrometry analysis and algorithm development. Their research is looking to identify biomarkers that indicate lung infection in a susceptible patient population.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Boston Children's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration between Bill Lionheart and Gerhard Wolf</gtr:description><gtr:id>5139FCAD-D8BA-49CB-AAD4-B76355116D1B</gtr:id><gtr:outcomeId>b971dd38b971dd4c-1</gtr:outcomeId><gtr:piContribution>The collaboration between Bill Lionheart (University of Manchester) and Gerhard Wolf (Children's Hospital Boston, US) was a product of the joint MIMIT-CIMIT Science Bridge activity. A call for proposals to bring together PI's from Manchester and Boston resulted in an application for project funding from Bill and Gerhard to work on developing a bedside imaging methodology for mechanically ventilated patients. The project has been looking at developing a methodology to reduce lung injury of patients mechanically ventilated. Gerhard's clinical expertise with Bill's expertise in mathematically modelling and algorithm development has combined to develop an algorithm to enable the real time use of EIT to measure lung damage. The aim is to use this methodology in a clinical setting to reduce lung injury.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brigham and Women's Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Hugh McCann, fellowship for Natasa Terzija</gtr:description><gtr:id>CA6BEE7E-A19C-45C2-B3F0-2ABC6CE99C19</gtr:id><gtr:outcomeId>b963fc22b963fc40-1</gtr:outcomeId><gtr:piContribution>Support for Dr Natasa Terzija to spend an agreed amount of time over in Boston, USA with Prof Ron Kikinis as part of her application to the EPSRC for a 5-year early-career Research Fellowship.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>427661</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR i4i Antimicrobial resistance Call (not yet announced)</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>0E55CB20-9CD4-4001-A124-428D74B21DFF</gtr:id><gtr:outcomeId>546c8553d0bb38.34281175</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1534638</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Robust Repeatable Respiratory Monitoring with EIT</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>6E49CD80-14D1-4B12-979B-2F5E5608B516</gtr:id><gtr:outcomeId>546c87e9630934.89836329</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>527302</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Commission (EC)</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>FP7</gtr:fundingRef><gtr:id>4008A746-244D-4457-9D16-78477F612BF9</gtr:id><gtr:outcomeId>5ec625b65ec625ca</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>558640</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Karl Herholz EC FP7 grant INMiND</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>AB061EE6-E8CE-4099-9257-0AE0483C7540</gtr:id><gtr:outcomeId>5ec705a85ec705bc</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Karl Herholz NIHR Clinical Lectureship for David Coope</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>BD534EEC-8EF4-4787-B9E6-F3BDDA95463B</gtr:id><gtr:outcomeId>r-6576672686.800987068ca24e</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The findings from the initial research collaborations have resulted awards of more than &amp;pound;3m follow finding. Software development to enable PET guided biopsies in Glioma patients This formed a crucial component in two major brain tumour projects funded under the CRUK and EPSRC Cancer imaging Centre building on the knowledge and experience acquired through this collaboration. 

Findings from another collaboration are being used to develop high throughput imaging assays using primary human tumour material.

 The methodology enabling the integration of images from MRI and EIT is enabling monitoring of key physiological functions (e.g. Lung).

Additionally the CIMIT:MIMIT collaborations enabled by this grant have enabled Junior Faculty (Academic and Clinical) Engagement and Exchange initiatives to be set up by Manchester Academic Health Science Centre, MIT and Harvard Medical School. These have resulted in approximately &amp;pound;1m grant awards.</gtr:description><gtr:firstYearOfImpact>2012</gtr:firstYearOfImpact><gtr:id>475AC868-5AC1-44A4-86AF-1CBA9BAACFE9</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d4551b2f9062.64798293</gtr:outcomeId><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Seven distinct projects were provided funding all with the aim of developing new methodologies or technologies to have an impact on healthcare. Each project was a partnership of Manchester and Boston based academics and clinicians developed through the MIMIT-CIMIT collaboration.



Imaging of Functional Dynamics of the Lung: has used a software based platform to merge images from MRI and EIT modalities resulting in high temporal and spatial resolution. So far the technique has been used with phantoms and the next step is to assess the methodology looking at lung function in healthy volunteers.



The identification of pathogen-specific biomarkers in ventilator-associated pneumonia: identifying biomarkers from breath samples has technical challenges, and the group has demonstrated good quality samples can be obtained for mass spectometry analysis to identify potential volatile organic compound biomarkers. An algorithm is under development to aid analysis and biomarker identification underway.



Multi-compartment carriers for fighting inflammation: development of the different compartments is underway to enable medical agents of different types to potentially be combined and applied topically in a directed manner, especially for the treatment of psoriasis. The compartments will need to be added to a single backbone and testing completed.



Using PET and diffusion weighted MRI in the OR to facilitate glioma tumour management: the group has developed a technique to integrate imaging of brain tumours within a surgical setting to enhance biopsy sampling, resulting in improved tumour grading and ultimately patient treatment.



Reducing ventilator-associated lung injury through the development of continuous non-invasive image guidance: development of an algorithm to monitor lung over distension is being developed to enable the use of EIT at the bedside on patients who are mechanically ventilated.



Making an &amp;quot;IMPACT&amp;quot; (integrated measuring platform for identifying and testing anti-cancer therapeutics): childhood cancer cell lines have been optimised in a 3D cell culture platform designed to measure cellular behaviour in response to drug treatment. Differing drug treatments have been studied and the aim is further assess cell responses to other possible therapies that might have application in the treatment of childhood cancers.



Objective Voice Quality Analysis by Spectrogram Entropy: development of an algorithm to assess voice quality is underway using high quality voice sample sets and associated data. Further voice sampling is underway to expand the dataset and aid the development of a quantitative methodology for assessing voice quality.</gtr:description><gtr:exploitationPathways>For each of the projects further research is likely to be required, but the ultimate aim is to develop methodologies, technologies or techniques that improve healthcare procedures.</gtr:exploitationPathways><gtr:id>B1431C07-0972-4B0C-80BA-C4DDF7CF17F0</gtr:id><gtr:outcomeId>r-4191832350.745641779a288a</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Refinement and integration of 3D SLICER software with VVLink BrainLab has enabled screen shots taken with BrainLab to be integrated with co-ordinates of suitable biopsy locations identified using 3D SLICER to enable neurosurgeons to accurate pinpoint the position from which to take a glioma biopsy.</gtr:description><gtr:id>5F24A268-2012-4AFD-B829-1B9055A7BFF0</gtr:id><gtr:impact>Accurately pinpoints the position from which to take a glioma biopsy.</gtr:impact><gtr:outcomeId>r-3075890422.8693726fd5342a</gtr:outcomeId><gtr:title>Karl Herholz and Ron Kikinis refinement and integration of 3D SLICER software with VVLink Brain Lab</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5F4742BA-1608-4608-9927-E8F8811DD98D</gtr:id><gtr:title>Breath Analysis On The Intensive Care Unit: Screening Invasively Ventilated Patients For Lower Respiratory Tract Pathogens.</gtr:title><gtr:parentPublicationTitle>American Journal of Respiratory and Critical Care Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/180b3b81cf7a74182969ca06bba19a69"><gtr:id>180b3b81cf7a74182969ca06bba19a69</gtr:id><gtr:otherNames>Fowler Sj</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>546c849de54c54.05037532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97AD5E52-2CB0-491F-BC0C-4E5C1D5EE3F6</gtr:id><gtr:title>O7.10 * CORRELATION OF PRE-OPERATIVE LANGUAGE FMRI WITH INTRA-OPERATIVE DIRECT CORTICAL STIMULATION FINDINGS IN GLIOMA SURGERY IDENTIFIES POTENTIAL FALSE POSITIVE FMRI ACTIVATIONS WITH CONVENTIONAL ANALYSIS</gtr:title><gtr:parentPublicationTitle>Neuro-Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/966e39487bae1a77d0ed95044884aeb8"><gtr:id>966e39487bae1a77d0ed95044884aeb8</gtr:id><gtr:otherNames>Coope D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546c5cdf984fb4.44949250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC873B7F-7B2C-4710-B907-2363C377B951</gtr:id><gtr:title>Perceptual Evaluation of Voice Quality and Its Correlation with Acoustic Measurement</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b10f9c077afa417c1e15d005bf193e7"><gtr:id>1b10f9c077afa417c1e15d005bf193e7</gtr:id><gtr:otherNames>Jalalinajafabadi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>543ba48b349862.60036409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BC98014-8BD6-4670-BAB3-E6B8C283FDBA</gtr:id><gtr:title>in vivo imaging of translocator protein expression in gliomas by positron emission tomography (PET)</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/256dd169221a7aced9a9441b7988010a"><gtr:id>256dd169221a7aced9a9441b7988010a</gtr:id><gtr:otherNames>Zhangjie Su (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_3597096536140bd042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>750A5238-AE29-41D0-9325-16637223ED78</gtr:id><gtr:title>Mutual information as a measure of reconstruction quality in 3D dynamic lung EIT</gtr:title><gtr:parentPublicationTitle>Journal of Physics: Conference Series</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8b8165742d6c3d4b1561625b0d89c91"><gtr:id>c8b8165742d6c3d4b1561625b0d89c91</gtr:id><gtr:otherNames>Crabb M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>543b9679a5cfc9.47328617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E561F03-47D9-4FBE-BFC3-1A10CE56D2EA</gtr:id><gtr:title>Validation of a Tablet-based Neurosurgery Virtual Reality Training Tool</gtr:title><gtr:parentPublicationTitle>Neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3c14792dc8bf72c6d84fe9c84750c4d"><gtr:id>e3c14792dc8bf72c6d84fe9c84750c4d</gtr:id><gtr:otherNames> Coope DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>546c5eda800645.73590725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C678E0A-9E0D-4E1C-ABAA-002443C6F914</gtr:id><gtr:title>Bioengineering approaches to study multidrug resistance in tumor cells.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cb30ec77aab64650e0a14b1adf26040"><gtr:id>5cb30ec77aab64650e0a14b1adf26040</gtr:id><gtr:otherNames>Fallica B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn><gtr:outcomeId>doi_53d02d02d4382190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7DB7CC4-99A9-4DCC-A80F-B7E2DEA2FDBD</gtr:id><gtr:title>Impact of model shape mismatch on reconstruction quality in electrical impedance tomography.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ca57906932fb6d882d845343cb0d5a1"><gtr:id>7ca57906932fb6d882d845343cb0d5a1</gtr:id><gtr:otherNames>Grychtol B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0278-0062</gtr:issn><gtr:outcomeId>doi_53d05e05e9c4817b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>405171D0-184E-41B6-B5A6-37A1F818221D</gtr:id><gtr:title>Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: a case-control study</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec4a98c29bce06f92b983ff3d062b557"><gtr:id>ec4a98c29bce06f92b983ff3d062b557</gtr:id><gtr:otherNames>Fowler SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>546c82a4cd90e9.36368260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0911F54F-70B8-4A52-B762-8D2FE4C2E6C3</gtr:id><gtr:title>The 18-kDa mitochondrial translocator protein in human gliomas: an 11C-(R)PK11195 PET imaging and neuropathology study.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0b305554ad541694efe530ad8e342b5"><gtr:id>d0b305554ad541694efe530ad8e342b5</gtr:id><gtr:otherNames>Su Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>56d023f4a90669.94117201</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA46EBBB-CBF3-43F1-AF9C-63849E6370B2</gtr:id><gtr:title>Mutual information as a measure of image quality for 3D dynamic lung imaging with EIT.</gtr:title><gtr:parentPublicationTitle>Physiological measurement</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cff4f0f868a88673b7cf52b477383e46"><gtr:id>cff4f0f868a88673b7cf52b477383e46</gtr:id><gtr:otherNames>Crabb MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0967-3334</gtr:issn><gtr:outcomeId>doi_55f95d95d5e815db</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEB01801-FD76-4452-A973-D1C64C404CBE</gtr:id><gtr:title>Intra-operative recording of direct cortical stimulation in low-grade gliomas using neuro-navigation for cross-validation of pre-operative motor and language functional MRI: feasibility and initial pilot data</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5170085a9932af2d5e00bbe4ddd6a4d5"><gtr:id>5170085a9932af2d5e00bbe4ddd6a4d5</gtr:id><gtr:otherNames>David Coope (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>m_122502718813dd5fb4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A8AD15B-FC37-4B05-900F-68B5414092B7</gtr:id><gtr:title>A Tablet-Based Virtual Environment for Neurosurgery Training</gtr:title><gtr:parentPublicationTitle>Presence: Teleoperators and Virtual Environments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bd6307da366f66e675669ac91d4e864"><gtr:id>7bd6307da366f66e675669ac91d4e864</gtr:id><gtr:otherNames>John N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d023788f4e01.96518874</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4E4275F-5B16-4DD0-B6D6-72094DD6F973</gtr:id><gtr:title>Co-registration and fusion of EIT images with MRI scan data</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/008b003d0a24dc574431c904c0259d0b"><gtr:id>008b003d0a24dc574431c904c0259d0b</gtr:id><gtr:otherNames>John Davidson (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>m_712577850913e58db0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1EC01F8D-2805-4DDB-BA3E-AF72A4A7BF07</gtr:id><gtr:title>Fusion of images obtained from EIT and MRI</gtr:title><gtr:parentPublicationTitle>Electronics Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2e5c2074b672d9a76267c502fbf1517"><gtr:id>d2e5c2074b672d9a76267c502fbf1517</gtr:id><gtr:otherNames>Davidson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>doi_53d03103140ab7ae</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FD3F038-F229-4FCE-A62C-6065AE52992F</gtr:id><gtr:title>MRI-informed functional EIT lung imaging</gtr:title><gtr:parentPublicationTitle>Proceedings 13th International Conference on Biomedical Applications of Electrical Impedance Tomography, May 23-25, 2012, Tianjin, China.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/116d0c73b1aa5fbcec9be254e5f5b062"><gtr:id>116d0c73b1aa5fbcec9be254e5f5b062</gtr:id><gtr:otherNames>J.L. Davidson</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>543b9780af7c11.41953542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>555B827A-F09A-4CE8-A685-63F514D4108A</gtr:id><gtr:title>Quantitative evaluation of white matter tract DTI parameter changes in gliomas using nonlinear registration.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6912bc9ab0db5e5469951843d9617860"><gtr:id>6912bc9ab0db5e5469951843d9617860</gtr:id><gtr:otherNames>Miller P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>543b957b2350b7.30672907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86E03570-77C8-461C-BC96-FEE71A0FA07B</gtr:id><gtr:title>Abstracts from the 2012 BNOS Conference</gtr:title><gtr:parentPublicationTitle>Neuro-Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93736099eed8a7007b0bac62be81a1b2"><gtr:id>93736099eed8a7007b0bac62be81a1b2</gtr:id><gtr:otherNames>Birks S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>546c5d16d5b2a6.68070449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61C6DDFB-F370-4C9F-A02D-E702FF941F9A</gtr:id><gtr:title>Alteration of cellular behavior and response to PI3K pathway inhibition by culture in 3D collagen gels.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cb30ec77aab64650e0a14b1adf26040"><gtr:id>5cb30ec77aab64650e0a14b1adf26040</gtr:id><gtr:otherNames>Fallica B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_53d0810817c53635</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G041733/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>E48C802F-8897-4353-910A-09D09331BB82</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical science &amp; disease</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>